Oncology & Cancer
Discovery of new T-cell raises prospect of 'universal' cancer therapy
Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a "one-size-fits-all" cancer therapy.
Jan 21, 2020
2
2414
Ovarian Cancer
Oncology & Cancer
Researchers uncover two-drug combo that halts the growth of cancer cells
UT Southwestern Simmons Cancer Center researchers have discovered a two-drug combo that halts the growth of cancer cells that carry HER2 mutations.
Jan 23, 2020
0
73
Medications
A novel pill to treat bleeding from uterine fibroids aims for FDA approval
For millions of premenopausal women, uterine fibroids turn their monthly periods into virtual hemorrhages.
Jan 23, 2020
0
1
Health
Breastfeeding and childbearing linked to lower early menopause risk
Results of a new epidemiological analysis of more than 108,000 women observed a lower risk of early menopause among women who had at least one pregnancy lasting at least six months and among those who had breastfed their ...
Jan 22, 2020
0
51
Oncology & Cancer
Large study shows no strong link between baby powder, ovarian cancer
(HealthDay)—There's been a longstanding debate—and a slew of lawsuits—over whether baby powder containing talc plays any role in the development of some cancers.
Jan 07, 2020
0
317
Alzheimer's disease & dementia
Protein associated with ovarian cancer exacerbates neurodegeneration in Alzheimer's
Houston Methodist scientists identified a protein found in ovarian cancer that may contribute to declining brain function and Alzheimer's disease, by combining computational methods and lab research.
Jan 13, 2020
0
16
Surgery
Despite effective therapy, US rate of breast conservation lower than other countries
Neoadjuvant systemic therapy (NST) can shrink tumors in breast cancer patients and in some cases allow for breast conserving therapy (lumpectomy) who would otherwise require a mastectomy. Yet, in the United States, about ...
Jan 08, 2020
0
0
Oncology & Cancer
NCI-MATCH: T-DM1 shows promising activity in salivary gland cancer
The antibody-drug conjugate ado-trastuzumab emtansine (T-DM1) has promising activity in HER2 amplified salivary gland tumors, according to data published in the Annals of Oncology. The publication is for 'Arm Q,' which is ...
Jan 07, 2020
0
2
Medical research
Step toward 'ink' development for 3-D printing a bioprosthetic ovary
For the first time, scientists identified and mapped the location of structural proteins in a pig ovary. Ongoing development of an "ink" with these proteins will be used for 3-D printing an artificial (or bio-prosthetic) ...
Jan 06, 2020
0
50
Genetics
Large study of genetic differences reveals several new targets for variety of diseases
While subtle differences in the number of genes copied from one individual and passed down to the next can be found in many healthy people, their role in disease may be much greater than previously thought.
Jan 14, 2020
0
11
Oncology & Cancer
Scientists unveil chemotherapy resistance mechanism related to p53 mutation
More than half of cancer cases worldwide are associated with genetic mutations in p53, the protein responsible for protecting DNA from changes that can lead to cancer. When this protein deforms, it not only loses its protective ...
Jan 09, 2020
0
12
Oncology & Cancer
New therapeutic strategy for chemotherapy resistance in ovarian cancer
A study from The Wistar Institute demonstrated that NAMPT, an enzyme critical for NAD+ biosynthesis, mediates selection of stem-like chemoresistant cells following cisplatin treatment. Researchers showed that a combination ...
Dec 20, 2019
0
4
Oncology & Cancer
Blood test can help GPs spot ovarian cancer in women with suspicious symptoms
Testing for levels of CA125 in the blood is a useful tool for gauging the likelihood of ovarian cancer and could help detect other types of cancer among patients in primary care, according to research presented at the 2019 ...
Nov 05, 2019
0
4
Medications
Addition of maintenance olaparib slows advanced ovarian cancer
(HealthDay)—Compared with placebo, the addition of olaparib to maintenance therapy with bevacizumab is associated with a significant progression-free survival benefit for patients with advanced ovarian cancer, according ...
Dec 19, 2019
0
0
Oncology & Cancer
Secondary surgery does not improve overall survival for recurrent ovarian cancer patients
Researchers from The University of Texas MD Anderson Cancer Center reported that secondary tumor-reduction, or cytoreduction, surgery followed by chemotherapy did not result in longer survival than chemotherapy alone in patients ...
Nov 13, 2019
0
3
Ovarian cancer is a cancerous growth arising from the ovary. Symptoms are frequently very subtle early on and may include: bloating, pelvic pain, difficulty eating and frequent urination, and are easily confused with other illnesses.
Most (more than 90%) ovarian cancers are classified as "epithelial" and are believed to arise from the surface (epithelium) of the ovary. However, some evidence suggests that the fallopian tube could also be the source of some ovarian cancers. Since the ovaries and tubes are closely related to each other, it is thought that these fallopian cancer cells can mimic ovarian cancer. Other types may arise from the egg cells (germ cell tumor) or supporting cells. These cancers are grouped into the category of gynecologic cancer.
This text uses material from Wikipedia licensed under CC BY-SA
